Snf 8815

• CAT Number: I036446
• CAS Number: 154336-13-7
• Molecular Formula: C56H68N10O13
• Molecular Weight: 1089.21
• Purity: 98%
• Synonyms: Snf 8815; Snf-8815; Snf8815; 28-Mephe-31-N-meile-cck (26-33)
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (3S,6S,9S,15R,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6-butyl-18-(4-hydroxybenzyl)-7-methyl-5,8,11,14,17,20-hexaoxo-15-((R)-1-phenylethyl)-4,7,10,13,16,19-hexaazatricosanedioic acid
• InChI: 1S/C56H68N10O13/c1-4-5-20-45(54(77)64-43(29-48(71)72)52(75)62-41(50(58)73)25-33-14-8-6-9-15-33)66(3)56(79)44(27-36-30-59-40-19-13-12-18-38(36)40)61-46(68)31-60-55(78)49(32(2)35-16-10-7-11-17-35)65-53(76)42(26-34-21-23-37(67)24-22-34)63-51(74)39(57)28-47(69)70/h6-19,21-24,30,32,39,41-45,49,59,67H,4-5,20,25-29,31,57H2,1-3H3,(H2,58,73)(H,60,78)(H,61,68)(H,62,75)(H,63,74)(H,64,77)(H,65,76)(H,69,70)(H,71,72)/t32-,39+,41+,42+,43+,44+,45+,49-/m1/s1
• InChIKey: VEJMMYDVUKVYEP-HYXUPHFQSA-N
• SMILES: N[C@H](C(N[C@@H](Cc1ccc(O)cc1)C(N[C@H]([C@H](C)c2ccccc2)C(NCC(N[C@@H](Cc3c4ccccc4[nH]c3)C(N(C)[C@@H](CCCC)C(N[C@@H](CC(O)=O)C(N[C@@H](Cc5ccccc5)C(N)=O)=O)=O)=O)=O)=O)=O)=O)CC(O)=O

SNF 8815 (Cat No.: I036446) is a synthetic small-molecule compound known for its potential biological activity, particularly in enzyme inhibition and receptor modulation. Though specific details about its mechanism are limited, SNF 8815 has been investigated in medicinal chemistry for its role in modulating cellular pathways relevant to cancer, inflammation, or neurological disorders. Its structure and function suggest potential as a lead compound in drug discovery. Further research is needed to fully understand its therapeutic applications and biochemical interactions in disease models.

Reference

1: Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH Jr. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology. 1994 Oct;107(4):1135-46. Review. PubMed PMID: 7523219.
2: Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci. 1994 Mar 23;713:439-41. PubMed PMID: 8018216.
3: Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993 Sep 1;53(17):3925-9. PubMed PMID: 8358719.